Your browser does not support JavaScript!
Logo de Labiotech.eu

Labiotech.eu Source d'actualité

Une actualité de Labiotech.eu a été ajouté(e)
Il y a 3 heures
On Our Way to Covid-19 Immunity
Safely developing immunity will be key to exiting the Covid-19 pandemic. Can testing for neutralizing antibodies against SARS-CoV-2 help pave the way? As the first reports of the newly emerging...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Aujourd'hui à 08:34
Eight Diseases CRISPR Technology Could Cure
CRISPR technology offers the promise to cure any human genetic disease with gene editing; which one will be the first? CRISPR-Cas9 was first used as a gene-editing tool in 2012. In just a few years,...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 5 jours
Artios-Novartis Pact Pushes Limits of DNA Repair in Cancer
A €1.1B deal struck this week between Novartis and the UK-based company Artios Pharma forges a new path for cancer drugs that target the DNA repair systems of our cells. As part of the deal — which...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 6 jours
How Augmented Reality Strengthens Biotech Manufacturing
Biotech and pharma companies are starting to implement augmented reality technologies at their manufacturing facilities, bringing forth a whole new world of possibilities. The Covid-19 pandemic has...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 1 semaine
Data Management: Taking the Right Turn at the Clinical Trial Crossroads
The success of a new drug depends on much more than its efficacy and safety or the ingenuity of its developers. Each clinical trial has multiple decision points, and taking the wrong turn at any of...
www.labiotech.eu
Charger plus d'actualités

Informations juridiques
SIREN / SIRET - DE Labiotech

Adresse
Berlin Berlin DE Allemagne